Donepezil (Aricept)

DRUG4 trials

Sponsors

Pfizer, University of Virginia

Conditions

Alzheimer DiseaseAlzheimer's DiseaseCaregiversDementiaParkinson Disease

Phase 2

Investigating the Cholinergic Contribution to Gait Dysfunction in Parkinson's Disease

CompletedNCT06903910

University of VirginiaParkinson Disease

Start: 2024-11-01End: 2026-01-31Updated: 2026-03-09

Phase 3

A Study of the Efficacy and Safety of Aricept in Patients With Severe Alzheimer's Disease Who Are Living in Skilled Nursing Homes

CompletedNCT00630851

PfizerAlzheimer Disease

Start: 2002-10-31End: 2004-10-31Updated: 2015-03-05

Unknown Phase

Combining a Caregiver Intervention With Aricept Treatment for Mild to Moderate Alzheimer's Disease

CompletedNCT00467766

PfizerAlzheimer Disease, Caregivers

Start: 1999-07-31End: 2003-06-30Updated: 2007-05-07

Effect of Aricept on Biomarkers (Acetylcholine, sAPP Alpha) In Cerebrospinal Fluid

CompletedNCT00987220

PfizerAlzheimer's Disease, Dementia

Start: 2009-10-31End: 2010-02-28Updated: 2011-02-14